secwatch.observer — SEC 8-K summary
======================================

Issuer:     PURE BIOSCIENCE, INC. (PURE)
CIK:        0001006028
Form:       8-K
Filed at:   2021-12-15T23:59:59+00:00
Accession:  0001493152-21-031569
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PURE Bioscience Q1 revenue plunges 65% to $497k; net loss widens to $796k
-------------------------------------------------------------------------

- Net product sales $497k, down 65% YoY; net loss $796k vs $180k; EPS $(0.01) vs $(0.00).
- Gross margin improved to 65% from 55% due to higher-margin product mix.
- Hired marketing firm; interviewing for Director of Sales; negotiating Canadian distributor contract.
- In-facility validation with second largest US produce processor; evaluating at 16-plant food processor chain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1006028/000149315221031569/0001493152-21-031569-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1006028/000149315221031569/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-21-031569

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer